Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma
- PMID: 12173339
- DOI: 10.1002/cncr.10541
Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma
Abstract
Background: The objective of this study was to report on the incidence of and factors related to the occurrence of central nervous system metastases in a cohort of patients who were diagnosed with colorectal, lung, breast, or kidney carcinoma or melanoma.
Methods: Using the population-based Maastricht Cancer Registry (MCR), a cohort was created of patients with colorectal carcinoma (n = 720 patients), lung carcinoma (n = 938 patients), breast carcinoma (n = 802 patients), renal carcinoma (n = 114 patients), and melanoma (n = 150 patients). The patients had to live in the catchment area of the University Hospital Maastricht (UHM) and had to have been diagnosed at the UHM during the period 1986-1995. Patients with brain metastases were searched for by linking the MCR to the Neuro-Oncology Registry of the UHM. Radiology files were checked as well. Follow-up lasted until December 31, 1998.
Results: Brain metastases were diagnosed in 232 patients (8.5%) in the cohort (n = 2724 patients). Of these patients, 84 patients were diagnosed with brain metastases within 1 month after their primary diagnosis, 82 patients were diagnosed with brain metastases within 1 year of their primary diagnosis, and 66 patients were diagnosed with brain metastases more than 1 year after their primary diagnosis. The cumulative incidence after 5 years was estimated at 16.3% in patients with lung carcinoma, 9.8% in patients with renal carcinoma, 7.4% in patients with melanoma, 5.0% in patients with breast carcinoma, and 1.2% in patients with colorectal carcinoma. The incidence was lower in patients age > or = 70 years compared with younger patients (breast and lung carcinoma), lower in patients who were diagnosed before 1991 compared with patients who were diagnosed after 1991 (breast and lung carcinoma), and lower in patients who had nonsmall cell lung carcinoma compared with patients who had small cell lung carcinoma.
Conclusions: The frequency of brain metastases in this cohort was highest in patients with lung carcinoma, followed by patients with renal carcinoma. There was no evidence of an increasing incidence of brain metastasis in patients with carcinoma of the breast or lung.
Similar articles
-
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.J Clin Oncol. 2004 Jul 15;22(14):2865-72. doi: 10.1200/JCO.2004.12.149. J Clin Oncol. 2004. PMID: 15254054
-
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Epidemiol Prev. 2016. PMID: 26951748
-
Systemic treatments for brain metastases from breast cancer, non-small cell lung cancer, melanoma and renal cell carcinoma: an overview of the literature.Cancer Treat Rev. 2014 Sep;40(8):951-9. doi: 10.1016/j.ctrv.2014.05.007. Epub 2014 May 27. Cancer Treat Rev. 2014. PMID: 24909312 Review.
-
Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery.J Neurosurg. 2002 Dec;97(5 Suppl):499-506. doi: 10.3171/jns.2002.97.supplement. J Neurosurg. 2002. PMID: 12507085
-
Identification of prognostic factors in patients with brain metastases: a review of 1292 patients.Int J Radiat Oncol Biol Phys. 1999 Mar 1;43(4):795-803. doi: 10.1016/s0360-3016(98)00442-8. Int J Radiat Oncol Biol Phys. 1999. PMID: 10098435 Review.
Cited by
-
Prioritizing Radiation and Targeted Systemic Therapies in Patients with Resected Brain Metastases from Lung Cancer Primaries with Targetable Mutations: A Report from a Multi-Site Single Institution.Cancers (Basel). 2024 Sep 26;16(19):3270. doi: 10.3390/cancers16193270. Cancers (Basel). 2024. PMID: 39409890 Free PMC article.
-
MicroRNAs in Lung Cancer Brain Metastasis.Int J Mol Sci. 2024 Sep 25;25(19):10325. doi: 10.3390/ijms251910325. Int J Mol Sci. 2024. PMID: 39408656 Free PMC article. Review.
-
Applications of cerebrospinal fluid circulating tumor cells and circulating tumor-derived DNA in diagnosis, prognosis, and personalized treatment of CNS metastases.Front Oncol. 2024 Sep 30;14:1409383. doi: 10.3389/fonc.2024.1409383. eCollection 2024. Front Oncol. 2024. PMID: 39403339 Free PMC article. Review.
-
A 3D Convolutional Neural Network Based on Non-enhanced Brain CT to Identify Patients with Brain Metastases.J Imaging Inform Med. 2024 Aug 26. doi: 10.1007/s10278-024-01240-5. Online ahead of print. J Imaging Inform Med. 2024. PMID: 39187703
-
Case report: Long-term intracranial effect of zimberelimab monotherapy following surgical resection of high PD-L1-expressing brain metastases from NSCLC.Front Oncol. 2024 May 10;14:1390343. doi: 10.3389/fonc.2024.1390343. eCollection 2024. Front Oncol. 2024. PMID: 38800395 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical